Skip to main content
. 2016 Sep 15;6:33205. doi: 10.1038/srep33205

Table 2. Univariate Analyses of Factors Associated with Overall Survival and Time to Recurrence.

Variable Overall Survival
Time to Recurrence
Hazard ratio (95% CI) p Value Hazard ratio (95% CI) p Value
Sex (male vs. female) 0.791(0.428–1.460) NS 0.850(0.454–1.427) NS
Age, y (>52 vs. ≤52) 1.061(0.645–1.745) NS 1.177(0.734–1.887) NS
AFP (ng/ml; >20 vs. ≤20) 1.235(0.741–2.060) NS 1.152(0.713–1.863) NS
Liver cirrhosis (yes vs. no) 1.627(0.701–3.777) NS 1.388(0.663–2.902) NS
ALT (units/L; >75 vs ≤75) 1.530(0.697–3.362) NS 1.138(0.492–2.630) NS
Tumor size (cm; >5 vs. ≤5) 1.732(1.028–2.917) 0.039 2.115(1.295–3.454) 0.003
Tumor number (multiple vs. single) 2.040 (1.034–4.026) 0.040 1.936 (1.010–3.708) 0.046
Vascular invasion (yes vs. no) 2.351 (1.423–3.883) 0.001 2.286 (1.416–3.691) 0.001
TNM stage (II/III vs. I) 2.351 (1.423–3.883) 0.001 2.273 (1.422–3.189) 0.001
Tumor differentiation (III/IV vs. I/II) 1.459 (0.855–2.490) 0.166 1.467 (0.887–2.427) NS
Tumor encapsulation (none vs. complete) 1.170 (0.711–1.926) 0.536 1.268 (0.790–2.034) NS
STYK1(high vs. low) 2.479 (1.476–4.161) 0.001 2.582 (1.573–2.238) <0.001

NOTE: Univariate analysis, Cox proportional hazards regression model.

Abbreviation: 95% CI, 95% confidence interval; AFP, alpha-fetoprotein; NS, not significant(Cox proportional hazards regression model); TNM, tumor-node-metastasis.